Current Role(s): Senior Vice President; Head of Multiple Sclerosis
Joined Genzyme: 2011
Bill Sibold is responsible for Genzyme’s Multiple Sclerosis franchise as the company prepares to launch two products.
- Senior Vice President and Chief Commercial Officer, Avanir Pharmaceuticals
- President and Chief Executive Officer, Lycera Corporation
- Senior Vice President of U.S. Commercial and various leadership positions for MS products, Biogen Idec
- M.B.A., Harvard University
- B.A., Yale University